See All Slides - tctmd.com

Slides

Presentation TCT 2012

A Prospective, Randomized Trial of N-Acetyl Cysteine and Sodium Bicarbonate in Patients with ST-Segment Elevation Myocardial Infarction

Presenter: Lisette Okkels Jensen

October 22, 2012

Presentation TCT 2012

The CTO Toolbox: What Do I Need in the Lab?

Presenter: Emmanouil Brilakis

October 22, 2012

Presentation TCT 2012

How Do You Get Everyone "Onboard"?

Presenter: Bruce Bowers

October 22, 2012

Presentation TCT 2012

CAS Decision Making in Octogenarians

Presenter: Michel Henry

October 22, 2012

Presentation TCT 2012

Branch or Embolize? Managing Iliac Aneurysms Involving the Hypogastrics

Presenter: James McKinsey

October 22, 2012

Presentation TCT 2012

Does CABG Convey a Survival Advantage Compared to PCI in Complex Patients and Lesions (and if so, why)?

Presenter: Patrick Serruys

October 22, 2012

Presentation TCT 2012

Justifying CTO PCI in the Era of Evidence-Based Medicine and Appropriate Use Criteria

Presenter: J. Aaron Grantham

October 22, 2012

Presentation TCT 2012

ACE-CTO: Angiographic Follow-up After Everolimus-eluting Stents in CTO

Presenter: Emmanouil Brilakis

October 22, 2012

Presentation TCT 2012

The Delphi Consensus and Its Validation: Guiding the Lesser Experienced Interventionalist on Patient Selection

Presenter: Sumaira Macdonald

October 22, 2012

Presentation TCT 2012

Debate II. Should Renal Artery Stenting Only Be Done Using FFR and IVUS? Con!

Presenter: Christopher White

October 22, 2012

Advertisement

Slides

A Prospective, Randomized Trial of N-Acetyl Cysteine and Sodium Bicarbonate in Patients with ST-Segment Elevation Myocardial Infarction

The CTO Toolbox: What Do I Need in the Lab?

How Do You Get Everyone "Onboard"?

CAS Decision Making in Octogenarians

Branch or Embolize? Managing Iliac Aneurysms Involving the Hypogastrics

Does CABG Convey a Survival Advantage Compared to PCI in Complex Patients and Lesions (and if so, why)?

Justifying CTO PCI in the Era of Evidence-Based Medicine and Appropriate Use Criteria

ACE-CTO: Angiographic Follow-up After Everolimus-eluting Stents in CTO

The Delphi Consensus and Its Validation: Guiding the Lesser Experienced Interventionalist on Patient Selection

Debate II. Should Renal Artery Stenting Only Be Done Using FFR and IVUS? Con!

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content